COLORADO’S pioneering biotech company Cannabis Science, Inc have released graphic photos of a patient, suffering with what their physician described as “the worst case of squamous cell carcinoma cancer” he had ever seen, being healed by cannabis oil administered at home.
For further details and photographic evidence visit
http://cannabiscureuk.wordpress.com
For further details and photographic evidence visit
http://cannabiscureuk.wordpress.com
COLORADO’S pioneering biotech company Cannabis Science, Inc have released graphic photos of a patient, suffering with what their physician described as “the worst case of squamous cell carcinoma cancer” he had ever seen, being healed by cannabis oil administered at home.
The first pictures released by Cannabis Science, Inc. show a tumour protruding the skull with two sinus-like holes in the top. Cannabis extract was then applied in and around the holes and to all of the surrounding tissue on the scalp whilst the patient was undergoing radiotherapy treatment which can be seen in the second photos. This kind of extract which contains cannabinoids such as THC and CBD is more commonly referred to as “hash oil” or “concentrate” in the fledging regulated cannabis industry in Colorado, most particularly, Denver. Colorado made it legal for patients with qualifying conditions, after citizens used ballot initiatives and petitions, to use Cannabis to treat their symptoms. MS, chronic pain and nausea are all qualifying conditions, not just life threatening ones.
Claims of cannabis’ ability to shrink tumours have been made for many years, but within the last decade the anecdotal evidence has stacked up to the point that pharmaceutical companies have started taking these claims more seriously. GW Pharmaceuticals, who are set to go global in 2012 with their cannabis tincture spray Sativex, are currently Phase III trialling their oromucosal mouth spray for cancer pain in both the UK and the US. It is already prescribed to a select number of MS suffers in parts of the UK and in continental Europe in countries such as Italy, Germany, Sweden and even Czech Republic this year.
In the United Kingdom Her Majesty’s Government insist on the truth of their statement “cannabis has no medicinal benefits”, and occasionally add “in herbal form” to account for the fact that they allow GW Pharmaceuticals to grow 300 tonnes of the plant a year for… medical purposes. But that’s OK, they are licensed to extract oil from it to make Sativex, which is due to embark on a new cancer pain market worth £millions this year. Because the product Sativex contains CBD, or cannabidiol, which can moderate the effects of THC’s euphoric or ‘high’ effect, but also prolong it as it slows down its break down in the body, meaning it can be used more effectively over a longer period of time. This is what we call an FAAH inhibitor. (Just a little bit of cannabis science for you!)
Cannabis Science Inc. claim this is potentially an $80bn cancer treatment industry....surprise surprise!
For the full article and photos visit: http://cannabiscureuk.wordpress.com
The first pictures released by Cannabis Science, Inc. show a tumour protruding the skull with two sinus-like holes in the top. Cannabis extract was then applied in and around the holes and to all of the surrounding tissue on the scalp whilst the patient was undergoing radiotherapy treatment which can be seen in the second photos. This kind of extract which contains cannabinoids such as THC and CBD is more commonly referred to as “hash oil” or “concentrate” in the fledging regulated cannabis industry in Colorado, most particularly, Denver. Colorado made it legal for patients with qualifying conditions, after citizens used ballot initiatives and petitions, to use Cannabis to treat their symptoms. MS, chronic pain and nausea are all qualifying conditions, not just life threatening ones.
Claims of cannabis’ ability to shrink tumours have been made for many years, but within the last decade the anecdotal evidence has stacked up to the point that pharmaceutical companies have started taking these claims more seriously. GW Pharmaceuticals, who are set to go global in 2012 with their cannabis tincture spray Sativex, are currently Phase III trialling their oromucosal mouth spray for cancer pain in both the UK and the US. It is already prescribed to a select number of MS suffers in parts of the UK and in continental Europe in countries such as Italy, Germany, Sweden and even Czech Republic this year.
In the United Kingdom Her Majesty’s Government insist on the truth of their statement “cannabis has no medicinal benefits”, and occasionally add “in herbal form” to account for the fact that they allow GW Pharmaceuticals to grow 300 tonnes of the plant a year for… medical purposes. But that’s OK, they are licensed to extract oil from it to make Sativex, which is due to embark on a new cancer pain market worth £millions this year. Because the product Sativex contains CBD, or cannabidiol, which can moderate the effects of THC’s euphoric or ‘high’ effect, but also prolong it as it slows down its break down in the body, meaning it can be used more effectively over a longer period of time. This is what we call an FAAH inhibitor. (Just a little bit of cannabis science for you!)
Cannabis Science Inc. claim this is potentially an $80bn cancer treatment industry....surprise surprise!
For the full article and photos visit:
http://cannabiscureuk.wordpress.com
e-mail:
Homepage:
Comments
Display the following 7 comments